Ropes & Gray Logo
Page Translations

Jimmy Chen

Counsel
Languages: Chinese (Mandarin)
Areas of Practice
  • *
Jump to:

Jimmy Chen is counsel in the intellectual property transactions group and advises public and private companies, investors, entrepreneurs, and other clients on business transactions involving intellectual property, including licensing and technology transfers, joint ventures, mergers and acquisitions, and other strategic transactions that involve the commercialization of intellectual property or technology. Jimmy has represented clients in a variety of industries including software and hardware, big data and machine learning, semiconductors, entertainment, video games, theme parks, consumer products, life sciences and medical devices, and has experience in cross-border transactions, especially those involving Greater China.

Prior to joining Ropes and Gray, Jimmy was an associate at an international law firm in San Francisco where he represented a variety of private and public companies in technology and intellectual property transactions. Jimmy was also foreign legal counsel at a leading Chinese law firm in Shanghai where he represented multinational companies in cross-border transactions throughout Greater China and the Asia-Pacific region.

Experience

  • Represented DIRECTV in an agreement to acquire EchoStar's video distribution business DISH, including DISH TV and Sling TV, through a debt exchange transaction.
  • Represented TPG Capital in several transactions, including:
    • in its sale of Moleem Corporation, a Korean building materials company, to STIC Investments for approximately $346 million; and
    • in its investment in DirecTV with AT&T Inc. to establish a new company, DIRECTV, to own and operate the former AT&T U.S. and Puerto Rico video business unit consisting of satellite, streaming and IP video services.
  • Represented Crosspoint Capital Partners as leading investor in a €65 million Series A follow-on funding round for Ireland-based Everseen, a leading provider of AI-powered computer vision and hyper automation solutions. Also represented Everseen on various commercial and strategic matters.
  • Represented Altamont Capital Partners, a private investment firm based in the San Francisco Bay Area with more than $4 billion of assets under management, in numerous transactions, including:
    • in its agreement to sell Fox Racing, a leading global performance motocross, mountain bike and lifestyle gear brand, to Vista Outdoor Inc.;
    • in its sale of Excel Fitness, a leading Planet Fitness franchise group with over 90 locations across Texas, Oklahoma, Arkansas, Missouri, North Carolina and Virginia, to Olympus Partners; and
    • in its acquisition of Bishop Lifting Products, Inc., a market-leading, value-added distributor of lifting products and solutions, from SBP Holdings.
  • Represents PathAI, a leading provider of AI-powered technology tools and services for pathology, on its intellectual property and data strategy in connection with various strategic partnerships.
  • Represented Johnson & Johnson, Pfizer, Ginkgo Bioworks and other global pharmaceutical and life sciences companies in strategic collaborations, acquisitions and divestitures.
  • Represented Coherus BioSciences, Inc. in a $1.1 billion immune-oncology collaboration agreement with Junshi Biosciences directed towards the development and commercialization of Junshi’s programmed cell death protein (anti-PD-1) monoclonal antibody, toripalimab, in the United States and Canada.
  • Represented Shanghai-based biotechnology start-up LianBio, a newly founded company launched by life sciences investment firm Perceptive Advisors, in agreements with two California-based biotechnology companies MyoKardia and BridgeBio Pharma to expand their reach into China, the world’s second largest pharmaceutical market.
  • Represented Profluent, an Emeryville-based AI protein design company, on first-in-kind open-source-inspired license of OpenCRISPR-1 granting free access to its new customizable gene editor protein sequences designed with AI to individuals, academic laboratories, drug development companies, and others to use the technology enabling precision editing of the human genome for ethical research and commercial use.
  • Advised Blackstone in its $2 billion strategic collaboration to support Alnylam’s advancement of innovative RNA interference (RNAi) medicines that have the potential to transform the lives of patients suffering from a range of debilitating diseases.
  • Represented the Canada Pension Plan Investment Board in various royalty investment transactions, including the acquisition of tiered royalty interests on tafamidis, a pharmaceutical agent sold under the brand names Vyndaqel and Vyndamax, from Tafamidis Holdings, LLC, a Blackstone Life Sciences portfolio company, for up to $221 million in up-front proceeds and performance-based milestones.
  • Represented Lifespan, a leading academic healthcare system based in Providence, Rhode Island, in its acquisition of Saint Anne’s Hospital in Fall River and Morton Hospital in Taunton, Massachusetts, as part of the Steward Health Care System bankruptcy.
  • Represented ServiceMax, Inc., the leader in asset-centric field service management, in a business combination agreement with Pathfinder Acquisition Corporation, a publicly traded special purpose acquisition company to become a publicly traded company and other strategic matters.
  • Represented a digital health technology company in its technology collaboration with a leading medical devices company involving a clinical study for treatments of depression.
  • Represented a major publicly-traded technology company in connection with development and collaboration agreements for its virtual reality products.
  • Represented a leading publicly-traded developer of instruments and technology for the life sciences sector in its strategic collaboration with a cloud-based data analytics provider.
  • Represented Qorvo in numerous acquisitions of semiconductor and hardware companies including Decawave Ltd., a leading developer of ultra-wideband technology.
  • Represented a film production company in numerous licensing, merchandising, and other commercial agreements involving video games, television and film, consumer products, and other themed services.*
  • Represented a consortium of Chinese state-owned companies in its joint venture with an American film studio for the development of a first-class theme park in Beijing, China.*

*Experience prior to joining Ropes & Gray

Areas of Practice